FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients

NCT00129389 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1925

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Fluorouracil
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Paclitaxel

Sponsor

Spanish Breast Cancer Research Group

Collaborators

[object Object]